Core Laboratories Stock Target Price and Analyst Consensus

CLB
 Stock
  

USD 20.90  0.09  0.43%   

The current analyst and expert consensus on Core Laboratories is Sell with 4 hold recommendations. The current projected Core Laboratories target price consensus is 26.42 with 6 analyst opinions. One of the most common ways Core Laboratories analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Core Laboratories vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Core Laboratories. We strongly encourage you to use your own analysis of Core Laboratories to validate this buy or sell advice. Core Laboratories recommendation module provides expert sentiment on the projected Core Laboratories target price to derive its highest and lowest estimates based on target price standard deviation of 6.931. Continue to Macroaxis Advice on Core Laboratories to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  

Core Laboratories Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Core Laboratories target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Core Laboratories target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions6
Lowered Outlook0
Raized Outlook0
Sell
Most Core Laboratories analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Core Laboratories stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Core Laboratories, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Core Laboratories Target Price Projection

Core Laboratories' current and average target prices are 20.90 and 26.42, respectively. The current price of Core Laboratories is the price at which Core Laboratories NV is currently trading. On the other hand, Core Laboratories' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Core Laboratories Market Quote on 27th of November 2022

Low Price20.79Odds
High Price21.34Odds

20.9

Target Price

Analyst Consensus On Core Laboratories Target Price

Low Estimate17.5Odds
High Estimate36.0Odds
Number of Analysts6
Standard Deviation6.931

26.416

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Core Laboratories NV and the information provided on this page.

Core Laboratories Analyst Ratings

Core Laboratories' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Core Laboratories stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Core Laboratories' financials, market performance, and future outlook by experienced professionals. Core Laboratories' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Core Laboratories Target Price Projections

Core Laboratories's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Core Laboratories and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Core Laboratories depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Core Laboratories NV including analysis of its current option contracts.
Core Laboratories' latest option contracts expiring on 2022-12-16 are carrying combined implied volatility of 31.58 with a put-to-call open interest ratio of 1.18 over 30 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on 2022-12-16. The current put volume is at 66, with calls trading at the volume of 42. This yields a 1.57 put-to-call volume ratio. The Core Laboratories option chain provides detailed quote and price information for the current Core Laboratories NV option contracts. It shows all of Core Laboratories' listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-12-16 Option Contracts

Core Laboratories option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Core Laboratories' lending market. For example, when Core Laboratories' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Core Laboratories, he or she must hedge the risk by shorting Core Laboratories stock over its option's life.
The chart above shows Core Laboratories' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Core Laboratories' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Core Laboratories' option, there is no secondary market available for investors to trade.

Core Laboratories Maximum Pain Price across 2022-12-16 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Core Laboratories close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Core Laboratories' stock options are financial instruments that give investors the right to buy or sell shares of Core Laboratories common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Core Laboratories stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Core Laboratories' stock price goes up or down, the stock options follow.
Continue to Macroaxis Advice on Core Laboratories to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Core Laboratories In The Money Call Balance

When Core Laboratories' strike price is surpassing the current stock price, the option contract against Core Laboratories NV stock is said to be in the money. When it comes to buying Core Laboratories' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Core Laboratories NV are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Core Laboratories Current Options Market Mood

Core Laboratories' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Core Laboratories Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Core Laboratories' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Core Laboratories' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Core Laboratories' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Core Laboratories Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Core Laboratories is a key component of Core Laboratories valuation and have some predictive power on the future returns of a Core Laboratories.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Core Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Core Laboratories in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
16.7120.9725.23
Details
Intrinsic
Valuation
LowReal ValueHigh
18.7222.9827.24
Details
Naive
Forecast
LowNext ValueHigh
16.7821.0425.30
Details
Earnings
Estimates (5)
LowProjected EPSHigh
0.550.660.70
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Core Laboratories. Your research has to be compared to or analyzed against Core Laboratories' peers to derive any actionable benefits. When done correctly, Core Laboratories' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Core Laboratories.

Additional Core Laboratories Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Core Laboratories is a key component of Core Laboratories valuation and have some predictive power on the future returns of a Core Laboratories.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Core Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Core Laboratories in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
16.7120.9725.23
Details
Intrinsic
Valuation
LowReal ValueHigh
18.7222.9827.24
Details
Naive
Forecast
LowNext ValueHigh
16.7821.0425.30
Details
Earnings
Estimates (5)
LowProjected EPSHigh
0.550.660.70
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Core Laboratories. Your research has to be compared to or analyzed against Core Laboratories' peers to derive any actionable benefits. When done correctly, Core Laboratories' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Core Laboratories.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Investor Favorites
Invested over 90 shares
Macroaxis Index
Invested over 90 shares
Baby Boomer Prospects
Invested over 90 shares
Continue to Macroaxis Advice on Core Laboratories to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
The data published in Core Laboratories' official financial statements usually reflect Core Laboratories' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Core Laboratories. For example, before you start analyzing numbers published by Core Laboratories accountants, it's critical to develop an understanding of what Core Laboratories' liquidity, profitability, and earnings quality are in the context of the Energy space in which it operates.
Please note, the presentation of Core Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Core Laboratories' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Core Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Core Laboratories NV. Please utilize our Beneish M Score to check the likelihood of Core Laboratories' management to manipulate its earnings.